Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
The Journal of Antimicrobial Chemotherapy|January 18, 2018
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimenCharlotte Charpentier, Isabelle Malet, Elisabeth Andre-Garnier, et al.
International Journal of Antimicrobial Agents|April 9, 2013
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failureAnne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, et al.
Viruses|February 28, 2020
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in VitroRomina Salpini, Lorenzo Piermatteo, Arianna Battisti, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, et al.
Nature|September 27, 2019
FHL1 is a major host factor for chikungunya virus infectionLaurent Meertens, Mohamed Lamine Hafirassou, Thérèse Couderc, et al.
Comptes Rendus Biologies|May 14, 2021
FHL1 is a key player of chikungunya virus tropism and pathogenesisLaurent Meertens, Mohamed Lamine Hafirassou, Thérèse Couderc, et al.
BMJ Open|February 5, 2026
Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trialAnthony L'hostellier, Charles Kouanfack, Corine Chazallon, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2014
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasmaCathia Soulie, Diane Descamps, Maxime Grudé, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2017
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasmaCathia Soulie, Maxime Grudé, Diane Descamps, et al.
The Journal of Antimicrobial Chemotherapy|February 22, 2019
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patientsAnne-Genevieve Marcelin, Maxime Grude, Charlotte Charpentier, et al.
Pageof 23